Ye Weiguo's Form 4 filing
Gyre Therapeutics, Inc. (GYRE) · filed Jun 11, 2026
- Accession no.
- 0001140361-26-024929
- Filed
- Jun 11, 2026
- Trade date
- Jun 9-10, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $128.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ye WeiguoCIK 0001985496 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Common Stock | MOption exerciseAcquired | +14,500 | $0.75 | +$10,875 | 714,500 | Direct | |
| Jun 9, 2026 | Common Stock | SSaleDisposed | −14,500 | $6.14 | −$89,030 | 700,000 | Direct | |
| Jun 10, 2026 | Common Stock | MOption exerciseAcquired | +6,418 | $0.75 | +$4,813.5 | 706,418 | Direct | |
| Jun 10, 2026 | Common Stock | SSaleDisposed | −6,418 | $6.21 | −$39,855.78 | 700,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Common Stock | MOption exerciseDisposed | −14,500 | $0.00 | $0 | 847,919 | Direct | |
| Jun 10, 2026 | Common Stock | MOption exerciseDisposed | −6,418 | $0.00 | $0 | 841,501 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.